OBJECTIVES: To identify incidence and risk factors for new-onset gastrointestinal bleeding (GIB) in a medical intensive care unit (ICU), a topic for which there is a paucity of recent studies. DESIGN: Retrospective cohort study. SETTING: Medical ICUs at our tertiary-care hospital, from 2007 to 2013. PATIENTS: Patients who developed clinically significant GIB after entering the ICU. INTERVENTIONS: Univariable and multivariable analyses. MAIN OUTCOME MEASURES: Incidence and risk factors for development of GIB. RESULTS: 4439 patients entered the medical ICU without a pre-existing GIB and 58 (1.3%) developed GIB while in the ICU. Risk factors included length of ICU stay (OR per additional day 1. 06; 95% CI 1.04 to 1.09) and elevated creatinine on ICU admission (OR 2.35; 95% CI 1.18 to 4.68, p=0.02). Elevated bilirubin on ICU admission (OR 2.08; 95% CI 0.97 to 4.47, p=0.06), and elevated aspartate transaminase (AST) on ICU admission (OR 2.20; 95% CI 0.96 to 5.03, p=0.06) trended towards increased risk of GIB that did not meet statistical significance. Age, gender, admission coagulation studies and mechanical ventilation were not predictive of GIB. Among those patients with new-onset GIB in the ICU, 47% died during that hospitalisation, as compared with those 30% of those without a GIB, p<0.01. CONCLUSIONS: Onset of GIB is now an infrequent occurrence in the ICU setting; however those with elevated bilirubin, AST and creatinine upon admission, and with longer length of ICU stay appear at increased risk and may benefit from closer monitoring.
OBJECTIVES: To identify incidence and risk factors for new-onset gastrointestinal bleeding (GIB) in a medical intensive care unit (ICU), a topic for which there is a paucity of recent studies. DESIGN: Retrospective cohort study. SETTING: Medical ICUs at our tertiary-care hospital, from 2007 to 2013. PATIENTS: Patients who developed clinically significant GIB after entering the ICU. INTERVENTIONS: Univariable and multivariable analyses. MAIN OUTCOME MEASURES: Incidence and risk factors for development of GIB. RESULTS: 4439 patients entered the medical ICU without a pre-existing GIB and 58 (1.3%) developed GIB while in the ICU. Risk factors included length of ICU stay (OR per additional day 1. 06; 95% CI 1.04 to 1.09) and elevated creatinine on ICU admission (OR 2.35; 95% CI 1.18 to 4.68, p=0.02). Elevated bilirubin on ICU admission (OR 2.08; 95% CI 0.97 to 4.47, p=0.06), and elevated aspartate transaminase (AST) on ICU admission (OR 2.20; 95% CI 0.96 to 5.03, p=0.06) trended towards increased risk of GIB that did not meet statistical significance. Age, gender, admission coagulation studies and mechanical ventilation were not predictive of GIB. Among those patients with new-onset GIB in the ICU, 47% died during that hospitalisation, as compared with those 30% of those without a GIB, p<0.01. CONCLUSIONS: Onset of GIB is now an infrequent occurrence in the ICU setting; however those with elevated bilirubin, AST and creatinine upon admission, and with longer length of ICU stay appear at increased risk and may benefit from closer monitoring.
Entities:
Keywords:
DIAGNOSTIC AND THERAPEUTIC ENDOSCOPY; GASTROINTESTINAL BLEEDING
Authors: Mette Krag; Anders Perner; Jørn Wetterslev; Matt P Wise; Mark Borthwick; Stepani Bendel; Colin McArthur; Deborah Cook; Niklas Nielsen; Paolo Pelosi; Frederik Keus; Anne Berit Guttormsen; Alma D Moller; Morten Hylander Møller Journal: Intensive Care Med Date: 2015-04-10 Impact factor: 17.440
Authors: M Dietrich; C J Reuß; C Beynon; A Hecker; C Jungk; D Michalski; C Nusshag; K Schmidt; M A Weigand; M Bernhard; T Brenner Journal: Anaesthesist Date: 2020-01 Impact factor: 1.041
Authors: Suneil A Raju; Peter D Mooney; Karuna Kodali; Charmaine Toh; Daniel Kusumawidjaja; Naomi Hersey; Hugo Penny; Matthew Kurien; David S Sanders Journal: Frontline Gastroenterol Date: 2018-03-16
Authors: Pareen Vora; Ronald Herrera; Arto Pietila; Ulrich Mansmann; Gunnar Brobert; Markku Peltonen; Veikko Salomaa Journal: World J Gastroenterol Date: 2022-05-14 Impact factor: 5.374